Mild Cognitive Impairment (MCI)
0
Pipeline Programs
4
Companies
4
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Soterix MedicalNJ - Woodbridge
1 programTranscranial Alternating Current StimulationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Design TherapeuticsInsole and ankle device
Soterix MedicalTranscranial Alternating Current Stimulation
Mission TherapeuticsRICORDO-DTx
Novartistranscranial electric stimulation
Clinical Trials (4)
Total enrollment: 75 patients across 4 trials
An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
Start: Mar 2026Est. completion: May 2027
N/ANot Yet Recruiting
TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)
Start: Jan 2025Est. completion: Dec 2026
N/ARecruiting
EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069
Start: Dec 2024Est. completion: Aug 202660 patients
N/ARecruiting
Non-invasive Deep Brain Stimulation to Enhance Motor Skill Acquisition in Individuals With Mild Cognitive Impairment
Start: Jun 2021Est. completion: Jul 202415 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 75 patients
4 companies competing in this space